GeneDx Holdings Corp. (NASDAQ:WGSWW – Get Free Report) was the target of a significant growth in short interest in June. As of June 30th, there was short interest totaling 50,980 shares, a growth of 175.9% from the June 15th total of 18,477 shares. Based on an average trading volume of 79,097 shares, the days-to-cover ratio is presently 0.6 days.
GeneDx Price Performance
NASDAQ WGSWW opened at $0.00 on Tuesday. GeneDx has a 12 month low of $0.00 and a 12 month high of $0.13. The stock’s fifty day moving average price is $0.01 and its 200-day moving average price is $0.01.
GeneDx Company Profile
GeneDx is a molecular diagnostics company specializing in high-complexity genetic testing for rare and ultra-rare inherited disorders. The company leverages next-generation sequencing (NGS) technologies, including whole exome sequencing, targeted gene panels, and chromosomal microarray analysis, to deliver comprehensive diagnostic insights. Its services are designed to support clinicians in identifying genetic mutations that underlie pediatric and adult conditions, guiding patient management, treatment decisions, and genetic counseling.
Founded in 2000 by Dr.
Featured Stories
- Five stocks we like better than GeneDx
- The SK Hynix IPO and 2027’s AI Memory Squeeze
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
Receive News & Ratings for GeneDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneDx and related companies with MarketBeat.com's FREE daily email newsletter.
